Neisseria gonorrhoeae: Difference between revisions
No edit summary |
|||
| Line 21: | Line 21: | ||
==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== | ==Antibiotic Sensitivities<ref>Sanford Guide to Antimicrobial Therapy 2010</ref>== | ||
==Gram Negatives== | |||
{| class="wikitable" | {| class="wikitable" | ||
| align="center" style="background:#f0f0f0;"|''' | | align="center" style="background:#f0f0f0;"|'''Category''' | ||
| align="center" style="background:#f0f0f0;"|'''''' | | align="center" style="background:#f0f0f0;"|'''Antibiotic''' | ||
| align="center" style="background:#f0f0f0;"|'''N. gonorrhoeae''' | | align="center" style="background:#f0f0f0;"|'''[[N. gonorrhoeae]]''' | ||
|- | |- | ||
| Penicillins||Penicillin G||0 | | [[Penicillins]]||[[Penicillin G]]||0 | ||
|- | |- | ||
| ||Penicillin V||0 | | ||[[Penicillin V]]||0 | ||
|- | |- | ||
| Anti-Staphylocccal Penicillins||Methicillin||0 | | Anti-Staphylocccal [[Penicillins]]||Methicillin||0 | ||
|- | |- | ||
| ||Nafcillin/Oxacillin||0 | | ||Nafcillin/Oxacillin||0 | ||
|- | |- | ||
| || | | ||Dicloxacillin||0 | ||
|- | |- | ||
| Amino-Penicillins||AMP/Amox||0 | | Amino-[[Penicillins]]||[[AMP]]/[[Amox]]||0 | ||
|- | |- | ||
| ||Amox | | ||[[Amox-Clav]]||+ | ||
|- | |- | ||
| ||AMP-Sulb||+ | | ||[[AMP-Sulb]]||+ | ||
|- | |- | ||
| Anti-Pseudomonal Penicillins|| | | Anti-Pseudomonal [[Penicillins]]||[[Ticar-Clav]]||+ | ||
|- | |- | ||
| || | | ||[[Pip-Tazo]]||+ | ||
|- | |- | ||
| || | | [[Carbapenems]]||Doripenem||+ | ||
|- | |- | ||
| [[ | | ||[[Ertapenem]]||+ | ||
|- | |- | ||
| || | | ||[[Imipenem]]||+ | ||
|- | |- | ||
| || | | ||[[Meropenem]]||+ | ||
|- | |- | ||
| ||[[Aztreonam]]||+ | | ||[[Aztreonam]]||+ | ||
| Line 62: | Line 59: | ||
| [[Fluroquinolones]]||[[Ciprofloxacin]]||+* | | [[Fluroquinolones]]||[[Ciprofloxacin]]||+* | ||
|- | |- | ||
| ||Ofloxacin | | ||[[Ofloxacin]]||+* | ||
|- | |- | ||
| ||[[Levofloxacin]]||+* | | ||[[Levofloxacin]]||+* | ||
|- | |- | ||
| ||Moxifloxacin||+* | | ||[[Moxifloxacin]]||+* | ||
|- | |- | ||
| ||Gemifloxacin|| | | ||Gemifloxacin|| | ||
| Line 74: | Line 69: | ||
| ||Gatifloxacin||+* | | ||Gatifloxacin||+* | ||
|- | |- | ||
| 1st G [[ | | 1st G [[Cephalo]]||Cefazolin||+ | ||
|- | |- | ||
| 2nd G | | 2nd G [[Cephalo]]||[[Cefotetan]]||+/- | ||
|- | |- | ||
| ||Cefoxitin||+/- | | ||[[Cefoxitin]]||+/- | ||
|- | |- | ||
| ||Cefuroxime||+/- | | ||[[Cefuroxime]]||+/- | ||
|- | |- | ||
| 3rd/4th G | | 3rd/4th G [[Cephalo]]||[[Cefotaxime]]||+/- | ||
|- | |- | ||
| ||Cefizoxime||+/- | | ||Cefizoxime||+/- | ||
|- | |- | ||
| ||[[CefTRIAXone]]||+ | | ||[[CefTRIAXone]]||+ | ||
|- | |- | ||
| ||Ceftaroline||+ | | ||Ceftaroline||+ | ||
| Line 96: | Line 89: | ||
| ||[[Cefepime]]||+ | | ||[[Cefepime]]||+ | ||
|- | |- | ||
| Oral 1st G | | Oral 1st G [[Cephalo]]||Cefadroxil||0 | ||
|- | |- | ||
| ||[[Cephalexin]]||0 | | ||[[Cephalexin]]||0 | ||
|- | |- | ||
| Oral 2nd G | | Oral 2nd G [[Cephalo]]||Cefaclor||+/- | ||
|- | |- | ||
| ||Cefproxil||+/- | | ||Cefproxil||+/- | ||
|- | |- | ||
| ||Cefuroxime | | ||Cefuroxime||+/- | ||
|- | |- | ||
| Oral 3rd G | | Oral 3rd G [[Cephalo]]||Cefixime||+ | ||
|- | |- | ||
| ||Ceftibuten||+/- | | ||Ceftibuten||+/- | ||
|- | |- | ||
| ||Cefpodox/Cefdinir/Cefditoren||+ | | ||Cefpodox/ Cefdinir/ Cefditoren||+ | ||
|- | |- | ||
| [[Aminoglycosides]]||[[Gentamicin]]||0 | | [[Aminoglycosides]]||[[Gentamicin]]||0 | ||
| Line 118: | Line 111: | ||
| ||[[Amikacin]]||0 | | ||[[Amikacin]]||0 | ||
|- | |- | ||
| ||Chloramphenicol||+ | | ||[[Chloramphenicol]]||+ | ||
|- | |- | ||
| ||[[Clindamycin]]||0 | | ||[[Clindamycin]]||0 | ||
| Line 136: | Line 129: | ||
| Glycylcycline||Tigecycline||+ | | Glycylcycline||Tigecycline||+ | ||
|- | |- | ||
| | | Sulfonamides||[[TMP-SMX]]||+/- | ||
|- | |- | ||
| Urinary Agents||[[Nitrofurantoin]]||+ | | Urinary Agents||[[Nitrofurantoin]]||+ | ||
| Line 156: | Line 139: | ||
| ||[[Metronidazole]]||0 | | ||[[Metronidazole]]||0 | ||
|- | |- | ||
| ||Quinupristin dalfoppristin||+ | | ||Quinupristin-dalfoppristin||+ | ||
|- | |- | ||
| ||Linezolid|| | | ||[[Linezolid]]|| | ||
|- | |- | ||
| || | | ||Daptomycin||0 | ||
|- | |- | ||
| ||Colistimethate||0 | | ||Colistimethate||0 | ||
|- | |||
| ||Telavancin||0 | |||
|- | |||
| ||[[Vancomycin]]||0 | |||
|} | |} | ||
Revision as of 20:30, 25 March 2014
Background
- Commonly known as gonorrhea
- Fastidious gram-negative cocci
Clinical Features
Differential Diagnosis
Workup
Management
- Proctitis
- Epididymitis
- Infectious Tenosynovitis
- Septic Arthritis (General)
- Orchitis
- Gonorrheal Conjunctivitis
Disposition
Antibiotic Sensitivities[1]
Gram Negatives
| Category | Antibiotic | N. gonorrhoeae |
| Penicillins | Penicillin G | 0 |
| Penicillin V | 0 | |
| Anti-Staphylocccal Penicillins | Methicillin | 0 |
| Nafcillin/Oxacillin | 0 | |
| Dicloxacillin | 0 | |
| Amino-Penicillins | AMP/Amox | 0 |
| Amox-Clav | + | |
| AMP-Sulb | + | |
| Anti-Pseudomonal Penicillins | Ticar-Clav | + |
| Pip-Tazo | + | |
| Carbapenems | Doripenem | + |
| Ertapenem | + | |
| Imipenem | + | |
| Meropenem | + | |
| Aztreonam | + | |
| Fluroquinolones | Ciprofloxacin | +* |
| Ofloxacin | +* | |
| Levofloxacin | +* | |
| Moxifloxacin | +* | |
| Gemifloxacin | ||
| Gatifloxacin | +* | |
| 1st G Cephalo | Cefazolin | + |
| 2nd G Cephalo | Cefotetan | +/- |
| Cefoxitin | +/- | |
| Cefuroxime | +/- | |
| 3rd/4th G Cephalo | Cefotaxime | +/- |
| Cefizoxime | +/- | |
| CefTRIAXone | + | |
| Ceftaroline | + | |
| CefTAZidime | +/- | |
| Cefepime | + | |
| Oral 1st G Cephalo | Cefadroxil | 0 |
| Cephalexin | 0 | |
| Oral 2nd G Cephalo | Cefaclor | +/- |
| Cefproxil | +/- | |
| Cefuroxime | +/- | |
| Oral 3rd G Cephalo | Cefixime | + |
| Ceftibuten | +/- | |
| Cefpodox/ Cefdinir/ Cefditoren | + | |
| Aminoglycosides | Gentamicin | 0 |
| Tobramycin | 0 | |
| Amikacin | 0 | |
| Chloramphenicol | + | |
| Clindamycin | 0 | |
| Macrolides | Erythromycin | +/- |
| Azithromycin | +/- | |
| Clarithromycin | +/- | |
| Ketolide | Telithromycin | + |
| Tetracyclines | Doxycycline | +/- |
| Minocycline | +/- | |
| Glycylcycline | Tigecycline | + |
| Sulfonamides | TMP-SMX | +/- |
| Urinary Agents | Nitrofurantoin | + |
| Fosfomycin | + | |
| Other | Rifampin | + |
| Metronidazole | 0 | |
| Quinupristin-dalfoppristin | + | |
| Linezolid | ||
| Daptomycin | 0 | |
| Colistimethate | 0 | |
| Telavancin | 0 | |
| Vancomycin | 0 |
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
Table Overview
| ||||||||||||||||||||||||||||||||||||||||
See Also
Sources
- ↑ Sanford Guide to Antimicrobial Therapy 2010
